[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100586374":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":20,"centralContacts":24,"locations":34,"responsibleParty":111,"collaborators":113,"id":116,"slug":117,"hasResults":118,"nctId":119,"briefTitle":120,"officialTitle":120,"acronym":121,"eligibilityCriteria":122,"healthyVolunteers":118,"sex":123,"minAge":124,"maxAge":19,"enrollmentInfo":125,"targetDuration":19,"studyType":128,"phases":129,"briefSummary":131,"conditions":132,"keywords":134,"overallStatus":37,"whyStopped":19,"lastUpdateSubmitDate":139,"lastUpdatePostDateStruct":140,"startDateStruct":143,"completionDateStruct":145,"leadSponsor":147,"locationsCount":148},{"fullName":5,"class":6},"University Hospital Schleswig-Holstein","OTHER",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Hypofractionated Radiosurgery","EXPERIMENTAL","3 fractions with 9.5-10.5 Gy, total dose 28.5-31.5 Gy",[13],"Radiation: Hypofractionated Radiosurgery",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":19},"RADIATION","Image-guided stereotactic Linac based RT preferable with \"dedicated radiosurgery system\" such as CyberKnife",[9],null,[21],{"name":22,"affiliation":5,"role":23},"David Krug, MD","PRINCIPAL_INVESTIGATOR",[25,30],{"name":26,"role":27,"phone":28,"phoneExt":19,"email":29},"Oliver Blanck, PhD","CONTACT","+4943150026666","oliver.blanck@uksh.de",{"name":31,"role":27,"phone":32,"phoneExt":19,"email":33},"Frauke Walther-Clausnizer","+4943150026581","Frauke.Walther-Clausnizer@uksh.de",[35,55,61,71,82,95],{"facility":36,"status":37,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Saphir Radiosurgery Center Frankfurt am Main","RECRUITING","Frankfurt am Main","Hesse","60528","Germany","DE",{"type":44,"coordinates":45},"Point",[46,47],8.68417,50.11552,{"lat":47,"lon":46},[50,54],{"name":51,"role":27,"phone":52,"phoneExt":19,"email":53},"Christian Arnold, MD","+496967735910","arnold@saphir-rc.com",{"name":51,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":56,"status":57,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":58,"geoPoint":60,"contacts":19},"University Hospital Frankfurt","SUSPENDED",{"type":44,"coordinates":59},[46,47],{"lat":47,"lon":46},{"facility":62,"status":37,"city":63,"state":39,"zip":64,"country":41,"countryCode":42,"cosmosGeoPoint":19,"geoPoint":19,"contacts":65},"European Radiosurgery Center Munich","Munich","81377",[66,70],{"name":67,"role":27,"phone":68,"phoneExt":19,"email":69},"Alexander Muacevic, MD","+49894523360","alexander.muacevic@erc-munich.com",{"name":67,"role":23,"phone":19,"phoneExt":19,"email":19},{"facility":72,"status":73,"city":74,"state":75,"zip":76,"country":41,"countryCode":42,"cosmosGeoPoint":77,"geoPoint":81,"contacts":19},"Saphir Radiosurgery Center Norther Germany","ACTIVE_NOT_RECRUITING","Kiel","Schleswig-Holstein","24105",{"type":44,"coordinates":78},[79,80],10.13489,54.32133,{"lat":80,"lon":79},{"facility":83,"status":37,"city":74,"state":75,"zip":76,"country":41,"countryCode":42,"cosmosGeoPoint":84,"geoPoint":86,"contacts":87},"University Medical Center Schleswig-Holstein",{"type":44,"coordinates":85},[79,80],{"lat":80,"lon":79},[88,92,93],{"name":89,"role":27,"phone":90,"phoneExt":19,"email":91},"Stefan Huttenlocher, MD","+494312398990","stefan.huttenlocher@uksh.de",{"name":22,"role":23,"phone":19,"phoneExt":19,"email":19},{"name":89,"role":94,"phone":19,"phoneExt":19,"email":19},"SUB_INVESTIGATOR",{"facility":96,"status":37,"city":97,"state":98,"zip":99,"country":41,"countryCode":42,"cosmosGeoPoint":100,"geoPoint":104,"contacts":105},"CyberKnife Centrum Mitteldeutschland","Erfurt","Thuringia","99089",{"type":44,"coordinates":101},[102,103],11.03536,50.97734,{"lat":103,"lon":102},[106,110],{"name":107,"role":27,"phone":108,"phoneExt":19,"email":109},"Hans-Ulrich Herold, MD","+4936178172310","Hans-Ulrich.Herold@ckcm.de",{"name":107,"role":23,"phone":19,"phoneExt":19,"email":19},{"type":112,"investigatorFullName":19,"investigatorTitle":19,"investigatorAffiliation":19,"oldNameTitle":19,"oldOrganization":19},"SPONSOR",[114],{"name":115,"class":6},"University of Luebeck","100586374","hypofractionated-radiosurgery-for-localised-prostate-cancer-hypostat-iii-100586374",false,"NCT06914544","Hypofractionated Radiosurgery for Localised Prostate Cancer (HYPOSTAT-III)","HYPOSTAT-III","Inclusion Criteria:\n\n* Localised, histopathologically confirmed Prostate Cancer (cT1-T2c N0 M0)\n* Gleason-grade ≤7, ISUP Grade Group 1-3\n* Guideline-based staging\n* Age ≥ 18 years\n* PSA \\\u003C 20 ng\u002Fml\n* Volume of the prostate \\\u003C 80 cm³\n* IPSS-Score ≤ 12\n* Written informed consent\n\nExclusion Criteria:\n\n* History of prior pelvic radiotherapy\n* Previous transurethral resection, laser enucleation or prostate ablation\n* Contraindication to MRI or Fiducial marker implantation (e.g. gold allergy)\n* Relevant comorbidity thought to adversely affect treatment compliance\n* Legal incapacity or lack of informed consent","MALE","18 Years",{"count":126,"type":127},175,"ESTIMATED","INTERVENTIONAL",[130],"NA","Hypofractionated radiosurgery with 5 fractions is considered standard of care for localized prostate cancer. The investigators initiated this multicenter phase II prospective trial to analyse feasibility (toxicity) of hypofractionated radiosurgery with 3 fractions in patients with localised prostate cancer under the hypothesis that the ratio of patients with late GU and GI toxicity ≥ grade 2 after 1 year amounts to 8.4% and 1.3% and is significant lower than 16.4% and 5.7% currently.",[133],"Prostate Cancer",[133,135,136,137,138],"SBRT","CyberKnife","Radiosurgery","HYPOSTAT","2026-04-28",{"date":141,"type":142},"2026-04-29","ACTUAL",{"date":144,"type":142},"2025-12-10",{"date":146,"type":127},"2029-12-31",{"name":5,"class":6},6]